Kala Bio delays quarterly report to complete liquidity analysis

PUBT · 20h ago
Kala Bio delays quarterly report to complete liquidity analysis
  • Kala Bio will delay its Form 10-Q for the quarter ended September 30, 2026, pending analysis of liquidity and capital resources.
  • The company expects to file within five calendar days of the prescribed deadline.
  • No significant year-over-year change in operating results is anticipated.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-012407), on November 13, 2026, and is solely responsible for the information contained therein.